Researchers believe the discovery of a gene signature in healthy brains could help develop preventative treatments for Alzheimer's disease.
The gene signature echoes the pattern in which Alzheimer's disease spreads through the brain much later in life.
University of Cambridge academics say the findings could help uncover the molecular origins of the devastating disease, and may be used to develop preventative treatments for at-risk individuals well before symptoms appear.
Results, published in the journal Science Advances, identified a specific signature in the regions of the brain which are most vulnerable to Alzheimer's.
They found the body's defence mechanisms against the proteins partly responsible for Alzheimer's are weaker in these areas of the brain.
The results imply that healthy young people with a non-standard form of this specific gene signature may be more likely to develop Alzheimer's in later life, and would most benefit from preventative treatments if and when they are developed for human use.
Earlier this year, the same researchers proposed that "neurostatins" could be taken by healthy individuals to slow or stop the progression of Alzheimer's, in a similar way to how statins are taken to prevent heart disease.
The new research could help identify who would benefit most from taking these in early life.
Although a neurostatin for human use is still quite some time away, a shorter-term benefit of these results may be to breed genetically modified mice or other animals that repeat the full pathology of Alzheimer's, which is the most common way for scientists to understand this or any disease to develop new treatments.
Alzheimer's disease is currently incurable.
Its molecular origins are also unknown, and it is hoped the gene signature research will help explore why certain parts of the brain are more vulnerable than others.
"To answer this question, what we've tried to do is to predict disease progression starting from healthy brains," said senior author Professor Michele Vendruscolo, of the Centre for Misfolding Diseases at Cambridge's Department of Chemistry.
"If we can predict where and when neuronal damage will occur, then we will understand why certain brain tissues are vulnerable, and get a glimpse at the molecular origins of Alzheimer's disease."
Rosie Freer, a PhD student in the Department of Chemistry and the study's lead author, said: "I hope that these results will help drug discovery efforts - that by illuminating the origins of disease vulnerability, there will be clearer targets for those working to cure Alzheimer's disease."
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here